Non-Current Assets

Noncurrent deferred tax assets and other noncurrent tax assets

Pfizer Noncurrent deferred tax assets and other noncurrent tax assets increased by 2.7% to $9.97B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.4%, from $9.54B to $9.97B. Over 5 years (FY 2020 to FY 2025), Noncurrent deferred tax assets and other noncurrent tax assets shows an upward trend with a 32.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
Metric ID: non_current_assets_deferred_tax_assets_net_and_other_tax_2a3587

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.69B$2.76B$3.34B$5.67B$7.00B$7.14B$6.69B$7.30B$8.26B$8.35B$3.71B$4.94B$7.87B$7.91B$8.66B$9.54B$10.34B$11.05B$9.70B$9.97B
QoQ Change—+2.3%+21.3%+69.6%+23.5%+1.9%-6.2%+9.1%+13.1%+1.1%-55.6%+33.4%+59.2%+0.5%+9.5%+10.2%+8.4%+6.8%-12.2%+2.7%
YoY Change————+159.9%+159.0%+100.3%+28.8%+18.0%+17.0%-44.6%-32.3%-4.8%-5.3%+133.7%+93.1%+31.5%+39.7%+12.0%+4.4%
Range$2.69B – $11.05B
CAGR+31.7%
Avg YoY Growth+44.4%
Median YoY Growth+23.4%

Frequently Asked Questions

What is Pfizer's noncurrent deferred tax assets and other noncurrent tax assets?
Pfizer (PFE) reported noncurrent deferred tax assets and other noncurrent tax assets of $9.97B in Q1 2026.
How has Pfizer's noncurrent deferred tax assets and other noncurrent tax assets changed year-over-year?
Pfizer's noncurrent deferred tax assets and other noncurrent tax assets increased by 4.4% year-over-year, from $9.54B to $9.97B.
What is the long-term trend for Pfizer's noncurrent deferred tax assets and other noncurrent tax assets?
Over 5 years (2020 to 2025), Pfizer's noncurrent deferred tax assets and other noncurrent tax assets has grown at a 32.4% compound annual growth rate (CAGR), from $2.38B to $9.70B.